Optic neuropathy in refractory neurosarcoidosis treated with TNF-α antagonist

被引：28

作者：

Salama, Batoul

Gicquel, Jean-Jacques

Lenoble, Patrice

Dighiero, Paul Louis

机构：

[1] Hop Jean Bernard, Dept Ophthalmol, F-86021 Poitiers, France

[2] Univ Poitiers Hosp, Federat Inter Hosp Picto Charentaise Ophthalmol, Poitiers, France

[3] Univ Poitiers Hosp, Dept Ophthalmol, Poitiers, France

[4] Univ Poitiers Hosp, Mulhouses Gen Hosp, Dept Ophthalmol, Poitiers, France

来源：

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE | 2006年 / 41卷 / 06期

关键词：

refractory neurosarcoidosis; optic neuropathy; infliximab;

D O I：

10.1139/I06-074

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Case report: To report a rare case of optic neuropathy in refractory neurosarcoidosis treated with tumour necrosis factor-cc antagonist (infliximab) perfusion. A 41-year-old man with diabetes presented with an abrupt, painless, unilateral visual loss. Thoracic computed tomography disclosed mediastinal lymphadenopathy, and evidence from histopathology confirmed sarcoidosis. Comments: Corticosteroids alone and with immunosuppressive agents failed to suppress the active disease. Alternative therapy of infliximab perfusions resulted in disease remission and relative visual improvement, and this treatment may warrant further clinical studies.

引用

页码：766 / 768

页数：3

共 8 条

[1]

Baughman RP, 2001, SARCOIDOSIS VASC DIF, V18, P70

[2] Long-term treatment of refractory posterior uveitis with anti-TNFα (infliximab) [J].